PROTALIX BIOTHERAPEUTICS INC - COM (PLX)

CUSIP: 74365A101

Q3 2017 13F Holders as of 30 Sep 2017

Type / Class
Equity / COM
Total 13F shares
11,001,885
Share change
+2,633,011
Total reported value
$6,384,450
Put/Call ratio
0%
Price per share
$0.58
Number of holders
33
Value change
+$1,313,538
Number of buys
7
Number of sells
12

Quarterly Holders Quick Answers

What is CUSIP 74365A101?
CUSIP 74365A101 identifies PLX - PROTALIX BIOTHERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PROTALIX BIOTHERAPEUTICS INC - COM (PLX) as of Q3 2017

As of 30 Sep 2017, PROTALIX BIOTHERAPEUTICS INC - COM (PLX) was held by 33 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 11,001,885 shares. The largest 10 holders included HIGHBRIDGE CAPITAL MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, FEDERATED INVESTORS INC /PA/, CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM, UBS OCONNOR LLC, BRIDGEWAY CAPITAL MANAGEMENT INC, MORGAN STANLEY, WELLS FARGO & COMPANY/MN, BlackRock Inc., and UBS Group AG. This page lists 33 institutional shareholders reporting positions in this security for the Q3 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.